[1] Rabaan AA, Al-Ahmed SH, Bazzi AM, et al. Overview of hepatitis C infection, molecular biology, and new treatment. J Infect Public Health, 2020, 13(5): 773-783.
[2] Rockey DC, Friedman SL. Fibrosis Regression After Eradication of Hepatitis C Virus: From Bench to Bedside. Gastroenterology, 2021, 160(5): 1502-20.e1.
[3] European Association for the Study of the Liver. EASL Recommendations on Treatment of Hepatitis C 2016. J Hepatol, 2017, 66(1): 153-194.
[4] Kisseleva T, Cong M, Paik Y, et al. Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis. Proc Natl Acad Sci U S A, 2012, 109(24): 9448-9453.
[5] Iredale JP. Hepatic stellate cell behavior during resolution of liver injury. Semin Liver Dis, 2001, 21(3): 427-436.
[6] Krizhanovsky V, Yon M, Dickins R A, et al. Senescence of activated stellate cells limits liver fibrosis. Cell, 2008, 134(4): 657-667.
[7] Wang S, Friedman SL. Hepatic fibrosis: A convergent response to liver injury that is reversible. J Hepatol, 2020, 73(1): 210-211.
[8] Preaux AM, D'ortho MP, Bralet MP, et al. Apoptosis of human hepatic myofibroblasts promotes activation of matrix metalloproteinase-2. Hepatology (Baltimore, Md), 2002, 36(3): 615-622.
[9] Murphy R, Issa R, Zhou X, et al. Inhibition of apoptosis of activated hepatic stellate cells by tissue inhibitor of metalloproteinase-1 is mediated via effects on matrix metalloproteinase inhibition: implications for reversibility of liver fibrosis. J Biol Chem, 2002, 277(13): 11069-11076.
[10] Hernández-Gea V, Friedman S L. Autophagy fuels tissue fibrogenesis. Autophagy, 2012, 8(5): 849-850.
[11] Hernández-Gea V, Ghiassi-Nejad Z, Rozenfeld R, et al. Autophagy releases lipid that promotes fibrogenesis by activated hepatic stellate cells in mice and in human tissues. Gastroenterology, 2012, 142(4): 938-946.
[12] Amor C, Feucht J, Leibold J, et al. Senolytic CAR T cells reverse senescence-associated pathologies. Nature, 2020, 583(7814): 127-132.
[13] Perugorria MJ, Olaizola P, Labiano I, et al. Wnt-β-catenin signalling in liver development, health and disease. Nature Rev Gastroenterol Hepatol, 2019, 16(2): 121-136.
[14] Popov Y, Sverdlov DY, Bhaskar KR, et al. Macrophage-mediated phagocytosis of apoptotic cholangiocytes contributes to reversal of experimental biliary fibrosis. Am J Physiol Gastrointest Liver Physiol, 2010, 298(3): G323-334.
[15] Popov Y, Sverdlov DY, Sharma AK, et al. Tissue transglutaminase does not affect fibrotic matrix stability or regression of liver fibrosis in mice. Gastroenterology, 2011, 140(5): 1642-1652.
[16] Karsdal MA, Hjuler ST, Luo Y, et al. Assessment of liver fibrosis progression and regression by a serological collagen turnover profile. Am J Physiol Gastrointest Liver Physiol, 2019, 316(1): G25-G31.
[17] Rockey DC. Noninvasive assessment of liver fibrosis and portal hypertension with transient elastography. Gastroenterology, 2008, 134(1): 8-14.
[18] Singh S, Muir AJ, Dieterich DT, et al. American Gastroenterological Association Institute Technical Review on the Role of Elastography in Chronic Liver Diseases. Gastroenterology, 2017, 152(6): 1544-1577.
[19] Urban ML, Manenti L, Vaglio A. Fibrosis--A Common Pathway to Organ Injury and Failure. New Engl J Med, 2015, 373(1): 95-96.
[20] Birukawa N K, Murase K, Sato Y, et al. Activated hepatic stellate cells are dependent on self-collagen, cleaved by membrane type 1 matrix metalloproteinase for their growth. J Biol Chem, 2014, 289(29): 20209-20221. |
